Imugene Ltd (ASX:IMU)

Imugene Ltd (ASX:IMU)

Share Price
$ 0.02
0.001 (5.00 %)
Market Cap
$75.81 m
Proactive Investors - Run By Investors For Investors

Imugene Ltd

Imugene Ltd (ASX:IMU) is listed on the Australian Securities Exchange.

Market: ASX:IMU
52-week High/Low: A$0.04 / A$0.01
Sector: Pharma & Biotech
Market Cap: A$75.81M
col 3
col 4
col 5
col 6

Imugene Ltd Timeline

Imugene Ltd (ASX:IMU) has promoted Leslie Chong to the position of chief executive officer, as the company prepares for the critical milestone of dosing the patients in the gastric cancer Phase 1b/2 clinical trial in Asia.

Imugene gets ready to raise

Imugene Ltd (ASX:IMU) has been granted a trading halt by the ASX, pending details of a capital raising.
Proceeds will be used to initiate the company’s Phase 1b/2 clinical trial for its HER-Vaxx gastric cancer treatment and additional preclinical work on HER-Vaxx drug combinations. Shareholder approval will be sought for the placement priced at $0.0075 to sophisticated investors.
Copyright ©, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use